www.fdanews.com/articles/122376-covidien-fda-extends-review-of-opioid-pain-drug

Covidien: FDA Extends Review of Opioid Pain Drug

November 20, 2009

Covidien Plc said U.S. health regulators extended the review period of its experimental opioid pain drug by three months to Feb. 22, 2010.
Forbes